What You Should Know
Boehringer Ingelheim and Eko Health have introduced Eko Vet+™ | CANINEBEAT® AI, a digital auscultation solution designed to detect, visualize, and grade heart murmurs in dogs.The system utilizes the Eko CORE™ Digital Attachment, which amplifies heart sounds by 40 times and offers advanced noise cancellation.The CANINEBEAT® AI algorithm boasts over 95% sensitivity and specificity in detecting murmurs associated with structural heart disease.The solution targets myxomatous
Read More
Eko Devices
Eko Health’s SENSORA Secures National CMS Payment, Paving the Way for Widespread AI Cardiac Screening
What You Should Know:
- Eko Health, a leader in AI-powered cardiac and pulmonary care, announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a national payment for its SENSORA® platform under the Outpatient Prospective Payment System (OPPS).
- The landmark decision guarantees that hospitals and health systems can now receive crucial reimbursement for AI-enabled cardiac detection delivered right at the point of care in outpatient settings. The move
Read More
AI Digital Stethoscope Detects Heart Failure with Near-Echo Precision in Ghana
What You Should Know:
- Researchers from the G-ACT Foundation and Eko Health have announced groundbreaking results from the DAMSUN-HF (Detection and Management of Heart Failure with SENSORA in Underserved Nations) study.
- The prospective validation study demonstrated that AI-enabled digital auscultation can effectively identify Heart Failure with reduced Ejection Fraction (HFrEF) in patients who lack access to traditional echocardiography.
AI-Enabled Auscultation Achieves
Read More
Eko Health’s Telehealth Platform Expands Across 800 Hospitals
What You Should Know:
- Eko Health, a leader in AI-powered cardiac and pulmonary care, announced today that its telehealth platform is now used by health systems that operate over 800 hospitals across the U.S.
- By enabling the real-time streaming of high-fidelity heart and lung sounds, Eko is helping virtual care teams deliver more confident frontline diagnostics from anywhere.
Eko Health Expands Remote Diagnostic Capabilities with Web-Based Telehealth Platform
Eko Health, a
Read More
Eko Health’s SENSORA Platform Gains CMS Reimbursement and CPT Code for AI-Powered Cardiac Detection
What You Should Know:
- Eko Health, a leader in AI-powered cardiac and pulmonary care, today announced a major stride in expanding access to early heart disease detection. The Centers for Medicare & Medicaid Services (CMS) has included Eko's SENSORA platform in its July 2025 provisional update to the Hospital Outpatient Prospective Payment System (OPPS), assigning SENSORA's Category III CPT code to APC 5734, with a reimbursement rate of $128.90 per use.
- The Category III
Read More
Boehringer Ingelheim and Eko Health Partner to Bring AI-Powered Heart Disease Detection to Veterinary Medicine
What You Should Know:
- Boehringer Ingelheim, a global leader in animal health, and Eko Health, a pioneer in applying artificial intelligence (AI) for early disease detection, have announced a strategic collaboration. The partnership aims to enhance the early detection and diagnosis of heart disease in dogs by combining Boehringer's expertise in canine cardiology with Eko Health's powerful AI algorithms and digital stethoscopes.
- The collaboration will leverage Eko Health's
Read More
Eko Health Launches AI-Powered Stethoscope in the UK
What You Should Know:
- Eko Health, Eko Health, a global leader in AI-enabled cardiopulmonary care, today announced its launch in the United Kingdom—one of the world’s largest healthcare markets. UK clinicians can now purchase Eko’s CORE 500™ Digital Stethoscope, Eko+ Membership, and accessories through EkoHealth.com and Amazon UK, expanding access to AI-powered tools designed to support earlier detection of cardiovascular and respiratory disease.
- This expansion builds on Eko’s
Read More
AMA Issues CPT Code for Eko Health’s AI-Powered Cardiac Screening Tool
What You Should Know:
- Eko Health, a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced the issuance of a Category III Current Procedural Terminology (CPT) code by the American Medical Association (AMA) for its SENSORA™ platform.
-The newly issued Category III CPT code will be effective on July 1, 2025, and is the first step to coverage and reimbursement for SENSORA™, bringing advanced heart disease detection to clinicians across
Read More
LSU Becomes First College Sports Program to Use Eko AI-Powered Stethoscopes
What You Should Know:
- Eko Health, a leader in AI-powered cardiac care, has joined forces with LSU Athletics and Our Lady of the Lake Health to revolutionize heart health care for student-athletes.
- Through this groundbreaking partnership, LSU Athletics becomes the first college sports program to utilize Eko Health’s FDA-cleared CORE 500 digital stethoscopes and AI algorithms for early detection of heart conditions.
AI-Powered Stethoscopes to Enhance LSU Athletics
Read More
Eko Health Raises $41M to Scale AI-driven Heart, Lung Detection
What You Should Know:
- Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
- This funding, led by ARTIS Ventures, Highland Capital Partners, NTTVC, and Questa Capital, will fuel Eko's mission to expand access to its innovative platform in the U.S. and globally.
Building on a Strong Foundation of Innovation and Clinical Validation
This funding round comes on the heels of
Read More
